Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary

Achtnichts, L; Chan, A; Czaplinski, A; Derfuss, T; Du Pasquier, R; Findling, O; Gobbi, C; Hoepner, R; Kamber, N; Kamm, C P; Kuhle, J; Lalive, P; Lutterotti, A; Martin, R; Müller, S; Papadopoulou, A; Pot, C; Salmen, A; Schippling, S and Zecca, C (2019). Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and translational neuroscience, 3(1), 2514183X1882207. Sage Publications 10.1177/2514183X18822073

[img]
Preview
Text
Achtnichts, 2019, Specific aspects of immunotherapy.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (218kB) | Preview

More than a dozen substances are meanwhile available for the disease-modifying immunotherapy of multiple sclerosis (MS). However, for some substances, there is a clear difference between approval in Switzerland (Swissmedic) and neighboring countries (European Medicines Agency (EMA)). In addition, limitations imposed by the Swiss Federal Office of Public Health in the specialties list (SL) have significant effects on use in daily clinical practice. In the following, we present consensus recommendations, which were reviewed and agreed upon by the Scientific Advisory Board of the Swiss Multiple Sclerosis Society and the Swiss Neurological Society. We explicitly focus on practice-relevant differences in the approval of MS immunotherapies in Switzerland compared with the EMA area and discuss further limitations (SL) and their impact on the use in clinical practice. Immunotherapies with the same approval in Switzerland and the EMA area and symptomatic therapies are not discussed here.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Chan, Andrew Hao-Kuang; Hoepner, Robert; Kamber, Nicole; Kamm, Christian Philipp and Salmen, Anke

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2514-183X

Publisher:

Sage Publications

Language:

English

Submitter:

Chantal Kottler

Date Deposited:

19 Dec 2019 11:19

Last Modified:

19 Dec 2019 11:19

Publisher DOI:

10.1177/2514183X18822073

BORIS DOI:

10.7892/boris.136555

URI:

https://boris.unibe.ch/id/eprint/136555

Actions (login required)

Edit item Edit item
Provide Feedback